Satellos Bioscience Inc.
MSLE
$10.02
$0.849.15%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 61.84M | 69.91M | 27.71M | 34.61M | 38.22M |
| Total Receivables | 783.00K | 726.00K | 370.00K | 205.00K | 186.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 642.00K | 765.00K | 187.00K | 401.00K | 280.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 2.50M | 3.82M | 3.62M | 2.28M | 2.43M |
| Total Current Assets | 65.76M | 75.22M | 31.88M | 37.50M | 41.11M |
|
|
|||||
| Total Current Assets | 65.76M | 75.22M | 31.88M | 37.50M | 41.11M |
| Net Property, Plant & Equipment | 7.00K | 8.00K | 5.00K | 6.00K | 5.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 65.77M | 75.23M | 31.89M | 37.50M | 41.12M |
|
|
|||||
| Total Accounts Payable | 1.67M | 2.11M | 1.77M | 1.39M | 1.06M |
| Total Accrued Expenses | 4.16M | 2.35M | -- | 2.00M | 1.62M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 30.00K | 104.00K | 2.33M | 114.00K | 95.00K |
| Total Other Current Liabilities | 30.00K | 104.00K | 2.33M | 114.00K | 95.00K |
| Total Current Liabilities | 5.86M | 4.56M | 4.11M | 3.50M | 2.77M |
|
|
|||||
| Total Current Liabilities | 5.86M | 4.56M | 4.11M | 3.50M | 2.77M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 5.86M | 4.56M | 4.11M | 3.50M | 2.77M |
|
|
|||||
| Common Stock & APIC | 145.74M | 144.78M | 95.99M | 94.86M | 91.29M |
| Retained Earnings | -103.46M | -91.74M | -81.97M | -74.67M | -68.85M |
| Treasury Stock & Other | 17.63M | 17.62M | 13.76M | 13.81M | 15.91M |
| Total Common Equity | 59.91M | 70.66M | 27.78M | 34.00M | 38.35M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 59.91M | 70.66M | 27.78M | 34.00M | 38.35M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 59.91M | 70.66M | 27.78M | 34.00M | 38.35M |
|
|
|||||